Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Nelson

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Molecular Therapy. Nucleic Acids|September 8, 2023
PINE-TREE enables efficient enrichment of prime-edited hPSCsMary S Jia, Christopher E Nelson
Annual Review of Chemical and Biomolecular Engineering|May 6, 2016
Engineering Delivery Vehicles for Genome EditingChristopher E Nelson, Charles A Gersbach
Nature Biotechnology|March 11, 2016
Cas9 loosens its grip on off-target sitesChristopher E Nelson, Charles A Gersbach
Biorxiv : the Preprint Server for Biology|August 6, 2025
Standardizing a Protocol for Streamlined Synthesis and Characterization of Lipid Nanoparticles to Enable Preclinical Research and EducationShilpi Agrawal, Abbey L Stokes, Christopher E Nelson
Journal of Neuromuscular Diseases|March 19, 2025
Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skippingMade Harumi Padmaswari, Shilpi Agrawal, Christopher E Nelson
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 18, 2015
Technologies for controlled, local delivery of siRNASamantha M Sarett, Christopher E Nelson, Craig L Duvall
Advanced Drug Delivery Reviews|January 3, 2015
MiRNA inhibition in tissue engineering and regenerative medicineKelsey R Beavers, Christopher E Nelson, Craig L Duvall
Nature Reviews. Neurology|September 30, 2017
Genome engineering: a new approach to gene therapy for neuromuscular disordersChristopher E Nelson, Jacqueline N Robinson-Hamm, Charles A Gersbach
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2012
Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug releaseMukesh K Gupta, Travis A Meyer, Christopher E Nelson, et al.
Neoplasia (New York, N.Y.)|July 28, 2022
Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategiesAriel I Mundo, Abdussaboor Muhammad, Kerlin Balza, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Nucleic Acids|September 8, 2023
PINE-TREE enables efficient enrichment of prime-edited hPSCsMary S Jia, Christopher E Nelson
Annual Review of Chemical and Biomolecular Engineering|May 6, 2016
Engineering Delivery Vehicles for Genome EditingChristopher E Nelson, Charles A Gersbach
Nature Biotechnology|March 11, 2016
Cas9 loosens its grip on off-target sitesChristopher E Nelson, Charles A Gersbach
Biorxiv : the Preprint Server for Biology|August 6, 2025
Standardizing a Protocol for Streamlined Synthesis and Characterization of Lipid Nanoparticles to Enable Preclinical Research and EducationShilpi Agrawal, Abbey L Stokes, Christopher E Nelson
Journal of Neuromuscular Diseases|March 19, 2025
Preclinical development of genome editing to treat Duchenne muscular dystrophy by exon skippingMade Harumi Padmaswari, Shilpi Agrawal, Christopher E Nelson
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 18, 2015
Technologies for controlled, local delivery of siRNASamantha M Sarett, Christopher E Nelson, Craig L Duvall
Advanced Drug Delivery Reviews|January 3, 2015
MiRNA inhibition in tissue engineering and regenerative medicineKelsey R Beavers, Christopher E Nelson, Craig L Duvall
Nature Reviews. Neurology|September 30, 2017
Genome engineering: a new approach to gene therapy for neuromuscular disordersChristopher E Nelson, Jacqueline N Robinson-Hamm, Charles A Gersbach
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 15, 2012
Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug releaseMukesh K Gupta, Travis A Meyer, Christopher E Nelson, et al.
Neoplasia (New York, N.Y.)|July 28, 2022
Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategiesAriel I Mundo, Abdussaboor Muhammad, Kerlin Balza, et al.
Pageof 4